184 results on '"Shikuma C"'
Search Results
2. Failure to clear intra-monocyte HIV infection linked to persistent neuropsychological testing impairment after first-line combined antiretroviral therapy
3. Anti-Periodontopathic Antibody Response in Chronic HIV Infection
4. Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy
5. Determinants of epidermal nerve fibre density in antiretroviral-naïve HIV-infected individuals
6. A modified TZM-bl assay (MoCo-TZA) documents replication-competent HIV in circulating monocytes despite 2 years of antiretroviral therapy initiated early during acute infection
7. Anal squamous intraepithelial lesions among HIV positive and HIV negative men who have sex with men in Thailand
8. Acetyl-L-carnitine and nucleoside reverse transcriptase inhibitor-associated neuropathy in HIV infection
9. Differential prevalence and geographic distribution of hepatitis C virus genotypes in acute and chronic hepatitis C patients in Vietnam
10. Differential prevalence and geographic distribution of hepatitis C virus genotypes in acute and chronic hepatitis C patients in Vietnam
11. Age, apolipoprotein E4, and the risk of HIV dementia: the Hawaii Aging with HIV Cohort
12. Cenicriviroc, a dual CCR2 and CCR5 antagonist leads to a reduction in plasma fibrotic biomarkers in persons living with HIV on antiretroviral therapy
13. CD4+ T-cells expressing negative checkpoint receptors are associated with decreased mitochondrial oxidative phosphorylation in chronic HIV
14. Erratum to: Failure to clear intra-monocyte HIV infection linked to persistent neuropsychological testing impairment after first-line combined antiretroviral therapy
15. A Trial of Itraconazole or Amphotericin B for HIV-Associated Talaromycosis
16. Development and evaluation of a real-time polymerase chain reaction assay for the rapid detection of Talaromyces marneffei MP1 gene in human plasma
17. Regional cortical thinning associated with detectable levels of HIV DNA
18. Peripheral blood HIV DNA is associated with atrophy of cerebellar and subcortical gray matter
19. Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort.
20. Role of the Veterans Aging Cohort Study Index in Assessing Total Atherosclerotic Burden
21. Regional Cortical Thinning Associated with Detectable Levels of HIV DNA
22. Epidemiology, Seasonality, and Predictors of Outcome of AIDS-Associated Penicillium marneffei Infection in Ho Chi Minh City, Viet Nam
23. Prevalence of anal squamous intraepithelial lesions in HIV-positive and HIV-negative men who have sex with men in Thailand.
24. Aging, HIV-1 infection and neurocognitive function : Clinical correlates
25. HIV DNA and cognition in a Thai longitudinal HAART initiation cohort
26. Frequency of apolipoprotein E4 among older compared with younger HIV patients: Support for detrimental effect of E4 on survival
27. 449 HIV PROVIRAL DNA AND MONOCYTE CHEMOATTRACTANT PROTEIN 1 IN CEREBROSPINAL FLUID FROM HIV-1-INFECTED CHILDREN.
28. Insulin Resistance in the HIV-Infected Population: The Potential Role of Mitochondrial Dysfunction
29. HIV-Associated Wasting in the Era of Highly Active Antiretroviral Therapy: A Syndrome of Residual HIV Infection in Monocytes and Macrophages?
30. Symptomatic distal sensory polyneuropathy in HIV after age 50
31. EFFECTS OF NIACIN ON HORMONE SENSITIVE LIPASE AND LIPOPROTEIN LIPASE EXPRESSION IN PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS-LIPODYSTROPHY SYNDROME.
32. 276 EFFECTS OF NIACIN ON HORMONE SENSITIVE LIPASE AND LIPOPROTEIN LIPASE EXPRESSION IN PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS-LIPODYSTROPHY SYNDROME.
33. Antibiotic Susceptibility ofPasturella multocida
34. Effects of Niacin on Hormone Sensitive Lipase and Lipoprotein Lipase Expression in Patients with Human Immunodeficiency Virus-Lipodystrophy Syndrome
35. Preexisting resistance to nonnucleoside reverse-transcriptase inhibitors predicts virologic failure of an efavirenz-based regimen in treatment-naive HIV-1--infected subjects.
36. Changes in Weight and Lean Body Mass during Highly Active Antiretroviral Therapy.
37. Consequences and Determinants of Adherence to Antiretroviral Medication: Results from Adult Aids Clinical Trials Group Protocol 370
38. Sterol regulatory element-binding proteins and reactive oxygen species: potential role in highly-active antiretroviral therapy (HAART)-associated lipodystrophy
39. Treatment of bacterial meningitis with ceftizoxime
40. Use of ceftizoxime in the treatment of paediatric infections.
41. Neuropsychological abnormalities in patients with dementia in CRF 01_AE HIV-1 infection
42. Discordant plasma and cerebral spinal fluid cytokines/chemokines in relation to HIV-1-associated dementia
43. The Effects of Extended Release Niacin on Lipoprotein Sub-Particle Concentrations in HIV-Infected Patients
44. HIV PROVIRAL DNA AND MONOCYTE CHEMOATTRACTANT PROTEIN 1 IN CEREBROSPINAL FLUID FROM HIV-1-INFECTED CHILDREN.
45. Antibiotic Susceptibility of Pasturella multocida.
46. HIV disease progression and limited antiretroviral treatment options for a HIV-1 infected individual with myoclonic epilepsy associated with ragged red fibers
47. Plasma galectin-3 is associated with decreased glomerular filtration rate in chronic HIV.
48. In vitro evidence against productive SARS-CoV-2 infection of human testicular cells: Bystander effects of infection mediate testicular injury.
49. In vitro evidence against productive SARS-CoV-2 infection of human testicular cells: Bystander effects of infection mediate testicular injury.
50. COVID-19 vaccination and booster induced authentic-virus neutralizing antibody response is superior to SARS-CoV-2 natural infection induced response.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.